Treatment
Dopamine clinical trials
We’re tracking 27 recruiting studies that include Dopamine, each written for real people, not researchers, below.
Recruiting studies
- NCT07562932Recruiting
Norepinephrine vs dopamine for cardiogenic shock
This study compares two blood pressure support medicines (norepinephrine and dopamine) in adults with cardiogenic shock, a condition where the heart cannot pump enough blood. It aims to find which medicine works better for patients with this severe heart condition.
Gwangju, Jeollanam-doAges 19 years+ - NCT07322133RecruitingPhase 4
Comparing two blood pressure medicines for newborns with lung hypertension
This trial compares two medicines (dopamine and norepinephrine) to see which works better for raising blood pressure in newborns who have both low blood pressure and high blood pressure in the lungs. Both medicines are given through a vein to help stabilize your baby's blood pressure.
Sacramento, CaliforniaAges Up to 4 weeks - NCT07273526Recruiting
Adrenaline vs. Dopamine for septic shock in children
This study compares two medicines, adrenaline and dopamine, to see which works better for children with septic shock (a serious infection causing very low blood pressure) that does not improve with fluids.
Faisalābad, Punjab ProvinceAges 1 month–1 year - NCT04750070RecruitingPhase 3
Treating shock in young children with severe malnutrition and diarrhea
This study tests a treatment approach to help children who are in “shock” (their body is struggling to maintain blood flow and oxygen) caused by diarrhea and severe undernutrition. It may help care teams stabilize children faster and improve outcomes.
DhakaAges 1 month–4.9 years - NCT07045935RecruitingPhase 4
Metabolic effects of cabergoline in prolactinoma patients
This study looks at metabolic health (like blood sugar and cholesterol) in people with prolactinomas who are being treated with the drug cabergoline. It aims to understand how lowering prolactin affects the body's metabolism and may help guide better care for patients with this condition.
BaselAges 18 years+ - NCT05347238Recruiting
Dopamine or norepinephrine for low blood pressure in very preterm babies
This trial compares two common medicines—dopamine versus norepinephrine—to treat low blood pressure in very preterm babies who have suspected or confirmed late-onset bloodstream infection (sepsis). It may help doctors find which medicine works better and more safely for this specific situation.
Phoenix, ArizonaAges 5 months–7 months - NCT06422208Enrolling by invitationPhase 1
Parkinson's cell transplant trial using your own cells
This trial tests whether transplanting special dopamine-producing cells made from a patient's own skin cells can help treat Parkinson's disease. It is for people who have had Parkinson's for at least 5 years and still respond well to medication.
Boston, MassachusettsAges 55–80 - NCT05711082Recruiting
Testing brain monitoring and dopamine in healthy adults
This study tests how the brain responds during monitoring tasks related to dopamine (a brain chemical involved in movement and motivation). It’s meant for healthy volunteers, so you may help researchers understand how dopamine-related signals work in real time.
BronAges 18–45 - NCT06447740Recruiting
Stent vs. medication for narrowed kidney artery
This trial compares placing a tiny mesh tube (stent) to open the narrowed kidney artery versus continuing blood pressure medicines alone. It is for people whose high blood pressure is hard to control even with multiple medications and who have a blockage in the kidney artery that can be treated.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07732426Recruiting
Semaglutide and brain response to food in obesity with food addiction
This trial tests if semaglutide can change how your brain responds to food cues, like seeing or smelling food, in people with obesity and a tendency toward food addiction. It may help understand why some people struggle with overeating and how this medication could help.
SeoulAges 19–50 - NCT07663474Recruiting
Phone restriction and dopamine brain changes
This study looks at how restricting your mobile phone use affects a chemical in the brain called dopamine. Healthy iPhone users will have PET brain scans before and after limiting their phone time to see how it changes dopamine transporters.
Busan, BusanAges 19–40 - NCT06675851RecruitingPhase 4
Dopamine changes in the brains of depressed and healthy people
This study uses brain scans to look at dopamine — a chemical messenger related to reward and mood — in people with depression and healthy volunteers. Researchers want to understand how dopamine changes in depression, which may lead to better treatments.
ViennaAges 18–65 - NCT04789915RecruitingPhase 1
Testing memantine added to dopamine-targeting treatment for early psychosis
This Phase 1 study tests whether adding memantine can improve “negative symptoms” (like low motivation, reduced emotional expression) in people having their first episode of psychosis. It’s designed to understand safety and early effects when dopamine-related treatment is adjusted.
Glostrup Municipality, Capitol RegionAges 18–45 - NCT07533799Recruiting
Swedish BioFINDER Sleep Study: Brain imaging in RBD and Parkinson's
This study examines brain changes in people with REM sleep behavior disorder (acting out dreams during sleep) and early Parkinson's disease using brain imaging scans. Researchers want to understand how sleep problems relate to Parkinson's development and find early warning signs.
MalmöAges 50–100 - NCT06763172RecruitingPhase 4
Caffeine's effect on learning in healthy adults
This study uses brain scans to see how caffeine affects the way we learn from rewards and punishments. You may be eligible if you are a healthy adult who drinks a moderate amount of caffeine daily.
Charlestown, MassachusettsAges 18–45 - NCT07423546RecruitingPhase 1/Phase 2
Brain scan study of Cobenfy in schizophrenia
This study tests a new medication called Cobenfy (also known as trospium) using brain scans to see how it affects dopamine in people with schizophrenia. If you have schizophrenia and are not currently on antipsychotics, you may be able to join.
New York, New YorkAges 18–50 - NCT07402928Recruiting
Dopamine signals in health and Parkinson's
This study uses MRI scans to look at dopamine signals in the brain. The goal is to understand how Parkinson's affects these signals.
HvidovreAges 35 years+ - NCT07404813Enrolling by invitation
Do family voices affect brain chemistry and pain in ICU patients?
This study tests whether hearing a family member's voice can change natural brain chemicals (dopamine and serotonin) and reduce pain for people in the intensive care unit who are in a coma but can still react. It may help improve comfort during recovery.
Malatya, MalatyaAges 18–65 - NCT07215884RecruitingPhase 1
Dopamine and movement in people who stutter
This study looks at how dopamine affects speech and movement in adults who stutter. It may help us understand why stuttering happens.
San Francisco, CaliforniaAges 18–65 - NCT06726785Recruiting
Gene changes in nasal cells of RLS patients on long-term dopamine agonist
This study looks at changes in a gene (DRD2) in nasal cells of people with Restless Legs Syndrome who are taking a dopamine agonist medication for a long time. It aims to understand how this gene might be involved in RLS.
San Francisco, CaliforniaAges 18–60 - NCT06568367RecruitingPhase 3
Solriamfetol for shift work disorder (SUSTAIN trial)
This study tests a medication called Solriamfetol (Sunosi) to see if it helps people with shift work disorder stay awake and alert during their shifts. It is a Phase 3 trial, which means it is being studied in a larger group to confirm how well it works and check for side effects.
Auburn, AlabamaAges 18–65 - NCT06413433RecruitingPhase 3
Solriamfetol for binge eating disorder
This study tests whether a drug called solriamfetol can help reduce binge eating episodes. It works on brain chemicals involved in mood and appetite control.
Encino, CaliforniaAges 18–55 - NCT06284382Recruiting
Early trauma and brain smell test study
This study looks at how early childhood trauma affects brain chemistry, specifically a chemical called dopamine, during smelling tasks. You will have brain scans and smell tests to see if your brain reacts differently.
BronAges 18–30 - NCT05909267Recruiting
Testing dopamine-targeted treatment for depression and body inflammation
This study looks at how changing dopamine signaling may affect motivation and movement in people with major depression, and it also involves healthy volunteers. It may help researchers understand whether dopamine changes can improve symptoms and how inflammation may relate to brain function.
SteglitzAges 18–65
What Dopamine is being studied for
Conditions with recruiting Dopamine studies.
Common questions
- Are there clinical trials studying Dopamine?
- Yes. Clin2 currently lists 27 recruiting studies that include Dopamine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Dopamine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Dopamine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Dopamine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.